MedPath

ATNAHS PHARMA UK LIMITED

🇦🇪United Arab Emirates
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

30

SFDA:16
NMPA:6
CANADA:4

Drug Approvals

Sodium Ibandronate Injection

Product Name
邦罗力
Approval Number
国药准字HJ20150097
Approval Date
Oct 25, 2024
NMPA

Sodium Ibandronate Injection

Product Name
邦罗力
Approval Number
国药准字HJ20150096
Approval Date
Oct 25, 2024
NMPA

Calcitriol Soft Capsules

Product Name
罗盖全
Approval Number
国药准字HJ20140598
Approval Date
Jan 24, 2024
NMPA

Sodium Ibandronate Injection

Product Name
邦罗力
Approval Number
H20150096
Approval Date
Dec 17, 2019
NMPA

Sodium Ibandronate Injection

Product Name
邦罗力
Approval Number
H20150097
Approval Date
Dec 17, 2019
NMPA

Calcitriol Soft Capsules

Product Name
罗盖全
Approval Number
H20140598
Approval Date
Jan 18, 2019
NMPA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.